Co-Diagnostics, Inc. and LGC Sign License Agreement for CoPrimer Technology

News (ZH) - Exclusive license agreement relates to use of CoPrimer™ technology for both research and commercial applications.

LGC acquires Seracare Life Sciences, strengthening its position in clinical quality control tools

News (ZH) - Strengthens LGC’s position across the spectrum of clinical quality control tools market

Science for a safer world

博客 - From our origins testing tobacco, alcohol and food products for adulteration in the 19thcentury, LGC has built a commitment to using science for a safer world.

Revolutionising cancer treatment one Array at a time

博客 - Pharmacogenetics, or the study of how people respond differently to medicines due to their genetics, is making a splash lately thanks to companies like Minneapolis, MN-based OneOme, which co-developed its RightMed test with Mayo Clinic

How genotyping is aiding in the fight against malaria

博客 - Recently, molecular biologists from LGC enabled a cutting edge study in collaboration with researchers from Brazil and the London School of Hygiene and Tropical Medicine to look for mutations in a sample of 516 male volunteers that could be used as clinical indicators for malaria-related complications

NuGEN and LGC announce collaboration agreement

News (ZH) - Benefit customers, expanding options to access SPET technology through SeqSNP service

LGC Genomics develops solution for genotyping thousands of markers

News (ZH) - Service allows customers to accelerate animal and plant breeding and bring products to market faster

LGC Genomics partners with Diagenode to expand NGS offering

News (ZH) - Distribution agreement to supply range of state-of-the-art sonication systems for DNA fragmentation

LGC Genomics strengthens leadership team to support launch of new NGS business unit

News (ZH) - Appointments further strengthen expertise to help drive development of NGS products and services

Innovate UK Awards Grant to MiNA Therapeutics and LGC LINK

News (ZH) - Funding to develop liver targeted gene activation therapies